Fatalities caused by novel opioids: a review

Drugs related to morphine represent not only large range of important therapeutic applications for the relief of moderate to severe pain but also give rise to a relatively large series of novel opioids that mimic the action of this naturally occurring analgesic. Most of these are based on fentanyl s...

Full description

Bibliographic Details
Main Author: Olaf H. Drummer
Format: Article
Language:English
Published: Taylor & Francis Group 2019-04-01
Series:Forensic Sciences Research
Subjects:
Online Access:http://dx.doi.org/10.1080/20961790.2018.1460063
id doaj-d8bfec540b504cd9b2a833dda105370e
record_format Article
spelling doaj-d8bfec540b504cd9b2a833dda105370e2020-11-25T00:11:39ZengTaylor & Francis GroupForensic Sciences Research2096-17902471-14112019-04-01429511010.1080/20961790.2018.14600631460063Fatalities caused by novel opioids: a reviewOlaf H. Drummer0School of Public Health and Preventive MedicineDrugs related to morphine represent not only large range of important therapeutic applications for the relief of moderate to severe pain but also give rise to a relatively large series of novel opioids that mimic the action of this naturally occurring analgesic. Most of these are based on fentanyl structures that are much more potent, and dangerous, than fentanyl itself. This publication reviews reports of fatalities attributed to 15 novel opioids with the view to assessing mortality associated with their misuse as well as reviewing published analytical procedures that would be able to detect these and other novel opioids. These drugs include reports of deaths to acetylfentanyl, acrylfentanyl, butr(yl)fentanyl, carfentanil, 2- and 4-fluorofentanyls, 4-fluorobutyrfentanyl, 4-fluoroisobutyrfentanyl, furanylfentanyl, α- and 3-methylfentanyls, 4-methoxyfentanyl, ocfentanil, as well as AH-7921, U-47700 and MT-45. Most of these cases reporting a drug-caused death involved other drugs in addition to the opioid. No obvious minimum fatal concentration was discerned for any of the opioids for which details were provided, however, the more potent members required detection limits well under 1 ng/mL and often even well below 0.1 ng/mL requiring use of the most sensitive mass spectral detection procedures, particularly when screening specimens using a non-targeted mode. Four other novel opioids have been reported in admissions to hospitals include 4-chloroisobutryfentanyl, cyclopentylfentanyl and tetrahydrofuranfentanyl, all of which are likely to have the potential to cause death. It is also likely that other analogues will appear with time.http://dx.doi.org/10.1080/20961790.2018.1460063Forensic scienceforensic toxicologyopioidspoisoningillicit drugsnovel psychoactive drugsfentanyl derivativesmass spectrometry
collection DOAJ
language English
format Article
sources DOAJ
author Olaf H. Drummer
spellingShingle Olaf H. Drummer
Fatalities caused by novel opioids: a review
Forensic Sciences Research
Forensic science
forensic toxicology
opioids
poisoning
illicit drugs
novel psychoactive drugs
fentanyl derivatives
mass spectrometry
author_facet Olaf H. Drummer
author_sort Olaf H. Drummer
title Fatalities caused by novel opioids: a review
title_short Fatalities caused by novel opioids: a review
title_full Fatalities caused by novel opioids: a review
title_fullStr Fatalities caused by novel opioids: a review
title_full_unstemmed Fatalities caused by novel opioids: a review
title_sort fatalities caused by novel opioids: a review
publisher Taylor & Francis Group
series Forensic Sciences Research
issn 2096-1790
2471-1411
publishDate 2019-04-01
description Drugs related to morphine represent not only large range of important therapeutic applications for the relief of moderate to severe pain but also give rise to a relatively large series of novel opioids that mimic the action of this naturally occurring analgesic. Most of these are based on fentanyl structures that are much more potent, and dangerous, than fentanyl itself. This publication reviews reports of fatalities attributed to 15 novel opioids with the view to assessing mortality associated with their misuse as well as reviewing published analytical procedures that would be able to detect these and other novel opioids. These drugs include reports of deaths to acetylfentanyl, acrylfentanyl, butr(yl)fentanyl, carfentanil, 2- and 4-fluorofentanyls, 4-fluorobutyrfentanyl, 4-fluoroisobutyrfentanyl, furanylfentanyl, α- and 3-methylfentanyls, 4-methoxyfentanyl, ocfentanil, as well as AH-7921, U-47700 and MT-45. Most of these cases reporting a drug-caused death involved other drugs in addition to the opioid. No obvious minimum fatal concentration was discerned for any of the opioids for which details were provided, however, the more potent members required detection limits well under 1 ng/mL and often even well below 0.1 ng/mL requiring use of the most sensitive mass spectral detection procedures, particularly when screening specimens using a non-targeted mode. Four other novel opioids have been reported in admissions to hospitals include 4-chloroisobutryfentanyl, cyclopentylfentanyl and tetrahydrofuranfentanyl, all of which are likely to have the potential to cause death. It is also likely that other analogues will appear with time.
topic Forensic science
forensic toxicology
opioids
poisoning
illicit drugs
novel psychoactive drugs
fentanyl derivatives
mass spectrometry
url http://dx.doi.org/10.1080/20961790.2018.1460063
work_keys_str_mv AT olafhdrummer fatalitiescausedbynovelopioidsareview
_version_ 1725402959989178368